Medicare Enrolled

Dr. Matthew Krauza, MD

Pulmonary Disease · Akron, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
95 ARCH ST, Akron, OH 44304
3302531411
In practice since 2006 (20 years)
NPI: 1740211309 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Krauza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krauza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Krauza

Dr. Matthew Krauza is a pulmonary disease specialist in Akron, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Krauza performed 411 Medicare services across 224 unique beneficiaries.

Between the years covered by Open Payments, Dr. Krauza received a total of $6,984 from 46 pharmaceutical and/or device companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Krauza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 411 Medicare services $6,984 industry payments

Medicare Practice Summary

Medicare Utilization ↗
411
Medicare services
Bottom 34% in OH for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
224
Unique beneficiaries
$138
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
265 $169 $1,652
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
41 $92 $600
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
38 $61 $424
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
29 $101 $1,060
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $75 $419
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
12 $94 $622
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,984
Total received (2018-2024)
Avg $998/year across 7 years
Top 22% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
371
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,920 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$673
2023
$753
2022
$1,513
2021
$1,564
2020
$1,138
2019
$881
2018
$463

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
United Therapeutics Corporation
$312
Inspire Medical Systems, Inc.
$164
GlaxoSmithKline, LLC.
$59
Electromed, Inc.
$34
JAZZ PHARMACEUTICALS INC.
$27
Mylan Specialty L.P.
$25
Insmed, Inc.
$22
Sandoz Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 79.6% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,392
AstraZeneca Pharmaceuticals LP
$755
Boehringer Ingelheim Pharmaceuticals, Inc.
$716
United Therapeutics Corporation
$575
Inspire Medical Systems, Inc.
$504
Actelion Pharmaceuticals US, Inc.
$333
GENZYME CORPORATION
$256
Genentech USA, Inc.
$193
HARMONY BIOSCIENCES LLC
$172
Mylan Specialty L.P.
$170
JAZZ PHARMACEUTICALS INC.
$169
Regeneron Healthcare Solutions, Inc.
$150
Mallinckrodt Hospital Products Inc.
$133
Electromed, Inc.
$112
Jazz Pharmaceuticals Inc.
$106
Baxter Healthcare
$95
Amgen Inc.
$90
Insmed, Inc.
$83
Merck Sharp & Dohme LLC
$79
Teva Pharmaceuticals USA, Inc.
$72
Astellas Pharma US Inc
$66
Takeda Pharmaceuticals U.S.A., Inc.
$63
Shire North American Group Inc
$60
Harmony Biosciences LLC
$60
Philips Electronics North America Corporation
$52
Novartis Pharmaceuticals Corporation
$52
Janssen Pharmaceuticals, Inc
$48
Bayer HealthCare Pharmaceuticals Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
Shionogi Inc
$35
ARBOR PHARMACEUTICALS, INC.
$32
PFIZER INC.
$31
Allergan Inc.
$29
Alexion Pharmaceuticals, Inc.
$26
Pulmonx Corporation
$26
PORTOLA PHARMACEUTICALS, INC.
$24
TETRAPHASE PHARMACEUTICALS, INC.
$19
PORTOLA PHARMACEUTICALS, LLC
$17
Sunovion Pharmaceuticals Inc.
$16
Sandoz Inc.
$15
Grifols USA, LLC
$15
Merck Sharp & Dohme Corporation
$15
Boston Scientific Corporation
$15
Resmed Corp
$14
Gilead Sciences, Inc.
$13
Horizon Therapeutics plc
$11
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACQUIRE · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · Astral · BREO · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · CRESEMBA · Cresemba · DIFICID · DUPIXENT · ELIQUIS · FARXIGA · FASENRA · Fetroja · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · Horizant · INSPIRE · Inspire Upper Airway Stimulation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · RAYOS · S&RC Und · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TREPROSTINIL · TYVASO · UPTRAVI · Ultomiris · Utibron · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xerava · Xolair · Xyrem · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Akron?
Compare pulmonary diseases in the Akron area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
37
Per 100K population
6.9
County median income
$71,016
Nearest hospital
AKRON CHILDREN'S HOSPITAL
0.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Krauza is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Krauza experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Krauza performed 265 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Krauza receive payments from pharmaceutical companies?
Yes. Dr. Krauza received a total of $6,984 from 46 companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krauza's costs compare to other pulmonary diseases in Akron?
Dr. Krauza's average Medicare payment per service is $138. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krauza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →